Neotropix

Neotropix

Lung Cancer Treatments | Neuroblastoma | Small Cell Lung Cancer Treatment.

HQ location
Malvern, United States
Launch date
Employees
Enterprise value
$6—8m
  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor investor

€0.0

round
N/A

$1.4m

Early VC
Total Funding000k
More about Neotropix
Made with AI
Edit

Neotropix operates in the health and wellness sector, focusing on the development and research of cannabidiol (CBD) products. The company targets individuals seeking natural remedies for anxiety, neural regeneration, and cancer treatment support. Neotropix's business model revolves around the extraction and formulation of CBD compounds from marijuana plants, which are then marketed and sold to consumers. Revenue is generated through direct sales of CBD products and potentially through partnerships with medical research institutions. The company leverages scientific research to validate the efficacy of its products, aiming to provide reliable and effective health solutions. Neotropix serves a growing market of health-conscious consumers looking for alternative treatments to traditional pharmaceuticals. The company’s commitment to research and innovation positions it as a key player in the evolving CBD industry.

Keywords: CBD, neural regeneration, anxiety relief, cancer treatment, natural remedies, health and wellness, cannabidiol, marijuana extraction, scientific research, alternative treatments.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo